Solid predominant histologic subtype and early recurrence predict poor postrecurrence survival in patients with stage I lung adenocarcinoma

被引:17
|
作者
Luo, Jizhuang [1 ]
Wang, Rui [1 ]
Han, Baohui [2 ]
Zhang, Jie [3 ]
Zhao, Heng [1 ]
Fang, Wentao [1 ]
Luo, Qingquan [4 ]
Yang, Jun [1 ]
Yang, Yunhai [1 ]
Zhu, Lei [3 ]
Chen, Tianxiang [1 ]
Cheng, Xinghua [5 ]
Huang, Qingyuan [1 ]
Wang, Yiyang [1 ]
Zheng, Jiajie [1 ]
Chen, Haiquan [1 ,5 ,6 ,7 ]
机构
[1] Shanghai Jiao Tong Univ, Shanghai Chest Hosp, Dept Thorac Surg, Shanghai, Peoples R China
[2] Shanghai Jiao Tong Univ, Shanghai Chest Hosp, Dept Pulm Med, Shanghai, Peoples R China
[3] Shanghai Jiao Tong Univ, Shanghai Chest Hosp, Dept Pathol, Shanghai, Peoples R China
[4] Shanghai Jiao Tong Univ, Shanghai Chest Hosp, Dept Shanghai Lung Tumor Clin Ctr, Shanghai, Peoples R China
[5] Fudan Univ, Dept Thorac Surg, Shanghai Canc Ctr, Shanghai, Peoples R China
[6] Fudan Univ, Inst Biomed Sci, Shanghai, Peoples R China
[7] Fudan Univ, Shanghai Med Coll, Dept Oncol, Shanghai, Peoples R China
基金
中国国家自然科学基金;
关键词
invasive lung adenocarcinoma; non-small cell lung cancer; postrecurrence survival; solid; stage I; RESPIRATORY SOCIETY CLASSIFICATION; IASLC/ATS/ERS CLASSIFICATION; INTERNATIONAL ASSOCIATION; PROGNOSTIC VALUE; ADJUVANT CHEMOTHERAPY; INDEPENDENT PREDICTOR; FOLLOW-UP; CANCER; REVISION; DISEASE;
D O I
10.18632/oncotarget.12540
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Introduction: This study investigated the correlation between histologic predominant pattern and postrecurrence survival (PRS), and identified the clinicopathologic factors influencing PRS in patients with completely resected stage I lung adenocarcinoma. Methods: A total of 136 stage I lung adenocarcinoma patients who experienced tumor recurrence after completely resection were included in this study. To analysis the association between histologic predominant pattern and PRS, invasive adenocarcinomas with mixed histologic components were divided into 2 groups: solid and nonsolid group (including lepidic, acinar, papillary, micropapillary) based on the histologic predominant pattern. PRS was analyzed to identify the prognostic predictors using the Kaplan-Meier approach and multivariable Cox models. Results: For all stage I invasive adenocarcinoma patients, the majority of postsurgical recurrences occurred within 2 years. Patients with solid predominant histological pattern were associated with unfavorable PRS (HR, 2.40; 95% CI 1.13-5.08, p=.022). There was a significant difference for poor PRS for patients who diagnosed tumor recurrence shorter than 12 months after surgery (HR, 2.34; 95% CI 1.12-4.90, p=.024). Extrathoracic metastasis was associated with poor media PRS in univariable analysis (p =.011), however, there was no significant PRS difference in multivariable analysis (HR, 1.56; 95% CI 0.65-3.73, p=.322) compared with intrathoracic metastasis. Conclusions: Solid predominant histologic subtype and recurrence free interval less than 12 months predict worse PRS in patients with stage I lung adenocarcinoma.
引用
收藏
页码:7050 / 7058
页数:9
相关论文
共 50 条
  • [1] Solid Predominant Histologic Subtype in Resected Stage I Lung Adenocarcinoma Is an Independent Predictor of Early, Extrathoracic, Multisite Recurrence and of Poor Postrecurrence Survival
    Ujiie, Hideki
    Kadota, Kyuichi
    Chaft, Jamie E.
    Buitrago, Daniel
    Sima, Camelia S.
    Lee, Ming-Ching
    Huang, James
    Travis, William D.
    Rizk, Nabil P.
    Rudin, Charles M.
    Jones, David R.
    Adusumilli, Prasad S.
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (26) : 2877 - +
  • [2] Correlation of survival and EGFR mutation with predominant histologic subtype according to the new lung adenocarcinoma classification in stage IB patients
    Sun, Yan
    Yu, Xinmin
    Shi, Xun
    Hong, Wei
    Zhao, Jun
    Shi, Lei
    WORLD JOURNAL OF SURGICAL ONCOLOGY, 2014, 12
  • [3] Value of adjuvant chemotherapy in patients with resected stage IB solid predominant and solid non-predominant lung adenocarcinoma
    Cao, Shuhui
    Teng, Jiajun
    Xu, Jianlin
    Han, Baohui
    Zhong, Hua
    THORACIC CANCER, 2019, 10 (02) : 249 - 255
  • [4] Impact of Solid Minor Histologic Subtype in Postsurgical Prognosis of Stage I Lung Adenocarcinoma
    Chen, Tianxiang
    Luo, Jizhuang
    Gu, Haiyong
    Gu, Yu
    Huang, Qingyuan
    Wang, Yiyang
    Zheng, Jiajie
    Yang, Yunhai
    Chen, Haiquan
    ANNALS OF THORACIC SURGERY, 2018, 105 (01) : 302 - 308
  • [5] Solid Predominant Subtype Is an Independent Risk Factor for Recurrence in Patients with Pathologic Stage I Adenocarcinoma
    Park, K.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S621 - S622
  • [6] Predominant histologic subtype in lung adenocarcinoma predicts benefit from adjuvant chemotherapy in completely resected patients: discovery of a holy grail?
    Russell, Prudence Anne
    Wright, Gavin Michael
    ANNALS OF TRANSLATIONAL MEDICINE, 2016, 4 (01)
  • [7] Micropapillary or solid pattern predicts recurrence free survival benefit from adjuvant chemotherapy in patients with stage IB lung adenocarcinoma
    Ma, Minjie
    She, Yunlang
    Ren, Yijiu
    Dai, Chenyang
    Zhang, Lei
    Xie, Huikang
    Wu, Chunyan
    Yang, Minglei
    Xie, Dong
    Chen, Chang
    JOURNAL OF THORACIC DISEASE, 2018, 10 (09) : 5384 - +
  • [8] Minor histological components predict the recurrence of patients with resected stage I acinar- or papillary-predominant lung adenocarcinoma
    Liu, Wei
    Zhang, Qian
    Zhang, Tiantian
    Li, Li
    Xu, Chunhua
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [9] The cribriform pattern identifies a subset of acinar predominant tumors with poor prognosis in patients with stage I lung adenocarcinoma: a conceptual proposal to classify cribriform predominant tumors as a distinct histologic subtype
    Kadota, Kyuichi
    Yeh, Yi-Chen
    Sima, Camelia S.
    Rusch, Valerie W.
    Moreira, Andre L.
    Adusumilli, Prasad S.
    Travis, William D.
    MODERN PATHOLOGY, 2014, 27 (05) : 690 - 700
  • [10] Histologic subtype component predicts lymph node micrometastasis and prognosis in patients with stage I lung adenocarcinoma
    Hung, Jung-Jyh
    JOURNAL OF THORACIC DISEASE, 2017, 9 (10) : 3623 - 3625